The company provides cell culture supplements derived from outdated human platelets that are subjected to a freeze-thaw process to induce growth factors release, allowing biotech companies and life sciences groups to meet the growing demand for cell culture media for all phases of research and development with stem cells. PL BioScience offers different safety grades of its products, including Research Grade, GMP Grade, and GMP-Clinical Grade, to meet the needs of its customers. Its mission is to enhance advances in cellular research and therapy with its forward-looking Technology: ELAREM™, a platform that unites tailored cell culture supplements based on Human Platelet Lysate. The human origin combined with a rich growth factor content not only supports cell growth but also enables various applications, covering all needs of cell expansion in academic research, pre-clinical research, and cellular therapy. PL BioScience aims to create a future of cell expansion that is animal suffering-free and benefits the regeneration potential of its platelet-derived products.